Multihance and Voltaren drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Multihance (gadobenate dimeglumine) and Voltaren (diclofenac sodium). Common drug interactions include nephrogenic systemic fibrosis among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Multihance and Voltaren. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Multihance?

Multihance has active ingredients of gadobenate dimeglumine. eHealthMe is studying from 5,786 Multihance users. Check the latest studies of Multihance.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.

On Jul, 28, 2026

13 people who take Multihance and Voltaren together, and have interactions are studied.

Multihance and Voltaren drug interactions.

What are the common drug interactions of Multihance and Voltaren, by gender? *:

female:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Skin fibrosis (fibrous tissue formation on skin)
Activities of daily living impaired
Arthralgia (joint pain)
Asthenia (weakness)
Back pain
Burning sensation
Deformity (disfigurement)
Groin pain
Hypoaesthesia (reduced sense of touch or sensation)

male:

Arthralgia (joint pain)
Back pain
Stress
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Fall
Joint lock
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Peroneal nerve palsy
Vascular calcification (deposits of calcium in the blood vessels)

What are the common drug interactions of Multihance and Voltaren, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Arthralgia (joint pain)
Back pain
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Fall
Joint lock
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Peroneal nerve palsy
Vascular calcification (deposits of calcium in the blood vessels)
Quality of life decreased

30-39:

n/a

40-49:

n/a

50-59:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Skin fibrosis (fibrous tissue formation on skin)
Joint range of motion decreased (disease of joint movement)
Muscle tightness
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Oedema peripheral (superficial swelling)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pruritus generalised (generalized itching)
Skin discolouration (change of skin colour)
Skin hypertrophy (skin cells enlarges)

60+:

n/a

What are the existing conditions these people have? *

Asthma: 7 people, 53.85%
Nuclear Magnetic Resonance Imaging Brain: 3 people, 23.08%
Tumor: 2 people, 15.38%
Thyroid Cancer: 2 people, 15.38%
Pain: 2 people, 15.38%
Oedema Peripheral (superficial swelling): 2 people, 15.38%
Joint Swelling: 2 people, 15.38%
Depression: 2 people, 15.38%
Blood Pressure Abnormal: 2 people, 15.38%
Back Pain: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Multihance and Voltaren?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously